24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
Oxford PharmaGenesis colleagues delivered a workshop on integrated evidence generation planning (IEGP) to Medical Affairs professionals at this year’s MAPS EMEA conference (Lisbon) in May. With a holistic and systematic approach, IEGP addresses many common challenges found in evidence generation planning.
We are proud to announce that Tomas Rees, Director of Innovation at Oxford PharmaGenesis, has been elected as the Chair-Elect for the ISMPP Board of Trustees. This is a prestigious and influential position that reflects Tomas’s expertise and leadership in the field of medical communications.
Digital health products are transforming the healthcare landscape and providing patients with new ways to manage and treat conditions. However, they come with several important considerations for medical communicators, especially when compared with traditional pharmaceuticals, explains Principal Medical Writer Caroline Leitschuh.
Oxford PharmaGenesis has been honoured with the first ever King’s Award for Enterprise, the most prestigious business award in the country, which recognizes the company’s excellence in International Trade.
PubMed is a website that files scientific research articles and shows their abstracts. PubMed can also show plain language summaries (PLS) of these articles when publishers tag the PLS correctly. PLS and open access, or free-to-read, publishing can help readers to find and use published research. In this study, we downloaded all of the available…
Effective innovation happens when we ask big questions. It’s part of what makes Oxford PharmaGenesis an award-winning, independent, global HealthScience communications consultancy. We innovate for clients through our transformative services. We offer expertise in publications, strategic medical communications, informatics and data science, patient engagement, value demonstration, Open Pharma, social media, and more.
